Characterizing Uncertainty: Insights from naturally occurring nanoscale structures in food and other lines of evidence Linda Abbott United States Department.

Slides:



Advertisements
Similar presentations
Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Advertisements

HLTH 340 Lecture A2 Toxicokinetic processes: absorption (part-1)
H3 Absorption of digested foods
Assessment Statements H.3.1 Draw and label a diagram showing a transverse section of the ileum as seen under a light microscope. H.3.2 Explain the structural.
1 Aflatoxin exposure, health impacts, risk assessment and database Aflatoxin Stakeholders’ Workshop 3-4 December, 2012 Dar es Salaam, Tanzania.
CE Introduction to Environmental Engineering and Science Readings for This Class: O hio N orthern U niversity Introduction Chemistry, Microbiology.
Session 11: Modeling Dispersion of Chemical Hazards, using ALOHA 1 Modeling Dispersion of Chemical Hazards, using ALOHA Prepared by Dr. Erno Sajo, Associate.
Ionization and dissociation of drugs-1
Osmosis, Osmotic pressure and Molecular processes.
Lessons Learned in Initiating and Conducting Risk Assessments within a Risk Analysis Framework: A FDA/CFSAN Approach Robert Buchanan DHHS Food and Drug.
Chapter 3 Diffusion and Osmosis.
Lipinski’s rule of five
ONAMI’s - Safer Nanomaterials and Nanomanufacturing Initiative Recommendations for the FDA Nanotechnology Task Force Stacey Harper.
Michael H. Dong MPH, DrPA, PhD readings Human Exposure Assessment II (8th of 10 Lectures on Toxicologic Epidemiology)
Cumulative Risk Assessment for Pesticide Regulation: A Risk Characterization Challenge Mary A. Fox, PhD, MPH Linda C. Abbott, PhD USDA Office of Risk Assessment.
What Do Toxicologists Do?
NIOSOMES.
Pharmacokinetics Chapter 4.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.
FAO/WHO CODEX TRAINING PACKAGE
Task Group 2 Alimentary Canal Environment The Dynamics of Engineered Nanomaterials in the Mammalian Alimentary Canal Environment Following Release from.
PRM 702 Project Risk Management Lecture #28
Nanomaterial Registry: Minimal Information Standards for Well-Characterized Nanomaterials in Environmental and Biological Studies Michele L. Ostraat April.
Nano WG 12 March Why in the world do we need a nanomaterials description system? – How CODATA and VAMAS answers that question Co-Chairs John Rumble.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
Utilizing Science & Technology and Innovation for Development Study the interaction of nanoparticles with proteins Marriott Hotel- Amman, August 13th,
Pharmacology Department
Is the passage of drug from its site of administration to its site of action through cell membranes. Sites of Administration Sites of action Cell membrane.
Prof. Hanan Hagar Pharmacology Department. What student should know  Major body fluid compartments  Concept of compartments.  Apparent volume of distribution.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
SAFETY PRECAUTIONS & TOXICITY RESEARCH NANOTECHNOLOGY.
Translating HPV Information into Plain Language Characterizing Chemicals in Commerce Austin, TX December, 12-14, 2006.
One of the most common serious diseases of the developing world is almost unknown in this country. It is Leishmanaisis, also known as kala- azar. After.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
Transport across Membranes & Drug Absorption Dr. Naila Abrar.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
BIOAVAILABILITY Time course of drug in the body: route of drug administration Oral vs IV injection Reasons for differences: completeness and rate of absorption.
Water and its Properties CP Biology: Chapter 2. The Water Molecule needed by all living things – parts of cells, fluid around cells (humans 65% water)
2-2 Properties of Water. The Water Molecule Like all molecules, a water molecule is neutral.
Pharmacology Department
DRUG ABSORPTION AND DISTRIBUTION OF DRUG
Absorption in the small intestine
Health and environmental impacts of nanoparticles: too early for a risk assessment framework? Prof Jim Bridges Emeritus Professor of Toxicology and Environmental.
Key Concepts on Health Risk Assessment of Chemical Mixtures.
The Digestive System and pH. Digestive System The digestive system is responsible for processing food, breaking it down into usable proteins, carbohydrates,
Aakash Patel, Dr. Supratim Ghosh IC-IMPACTS Summer Institute 2016
Pharmacokienetic Principles (2): Distribution of Drugs
Lipinski’s rule of five
Basic Principles: PK By: Alaina Darby.
Chapter 3 PHARMACOKINETICS “What the body does to the drug” Lei Wang
Pharmacology I BMS 242 Lecture II (Continued)
LIPOSOMES AS DRUG CARRIERS
A journey of nutrition p Part II
The main branches of pharmacology
Dr. Daniele Wikoff – ToxStrategies Experimental Biology 2017
Pharmaceutics 2.
Pharmacology I BMS 242 Lecture II (Continued)
Crystalloid and Colloid and dialysis. Crystalloid and Colloid Different biomolecules and their building blocks presented in biological system can be broadly.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Scientific rationale for EU regulatory expectations concerning product composition in case of Class-I and Class-III medicinal products Dr Ridha BELAIBA.
Virtual Screening.
Rules for Rapid Property Profiling from Structure
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Some of the pictures presented in this lecture are taken from
H3 Absorption of Digested Foods
How Can Standards for Graphene Nanomaterials Support TSCA Compliance?
Introduction to Pharmacology
Presentation transcript:

Characterizing Uncertainty: Insights from naturally occurring nanoscale structures in food and other lines of evidence Linda Abbott United States Department of Agriculture Office of Risk Assessment and Cost-Benefit Analysis

Uncertainty is associated with risk assessments of nanomaterials This is not unique to nanomaterials – uncertainty is expected in a risk assessment Sometimes uncertainty can be reduced Uncertainty should be characterized and communicated to the decision maker and the public

Uncertainty may be reduced Gathering more data about the nanomaterial Using different lines of evidence to fill data gaps Gathering more information about the issue to be addressed Using problem formulation to narrow the scope of the risk assessment

Using a tiered approach limits the need to reduce uncertainty Lower tiers use conservative assumptions as defaults when data are not available No need to reduce uncertainty further if the lower tier (screening) risk estimate is below the threshold of concern Reserves the use of sophisticated, more refined risk assessment techniques for situations where reducing uncertainty will have the greatest impact

Sources of Uncertainty in risk assessment of hypothetical nanomaterial in food Toxicity – Fewer oral toxicity tests for engineered nanomaterial (ENM )than for inhalation or dermal pathway Uptake and distribution of ENM in the human body may be a data gap Effect of the mixture of food and other substances in the digestive system may affect uptake Behavior of ENM in living organisms not well studied – under what circumstances will the ENM agglomerate or aggregate in fluid environments in the body

Data gaps may be filled by examining research in other disciplines Microbiology and virology Oral drug delivery Dietary supplements and vitamins Food science and technology Molecular gastronomy

Characteristics of successful orally delivered drugs Must cross biological membranes and enter systemic circulation to their site of action Lipanski’s Rule of 5 governs 90% of orally active drugs in commerce or phase II testing ≤ 5 H donors (∑OH & NH); ≤ 10 H acceptors (∑O & N); Molecular weight ≤ 500; ≤ 5 Log P octanol water Oral antibiotics, antifungals, vitamins and cardiac glycosides violate the Rule of 5 Computational approaches to evaluate oral absorption and permeability of potential drugs resulted in database

Characteristics of orally delivered drugs crossing mucosal barriers Surface densely coated with positive and negative charges resulting in a neutral surface (like IgG) Strong hydrophilic surface Lai et al., 2009 demonstrated that mucopenetrating particles as large as 200 nm are capable of traversing mucosal barriers

Drug delivery across tight junctions Reversibly open tight junction to allow passage of material Mucoadhesive – ionic interaction between positively charged carrier and negatively charged intestinal surface Chitosan - colloidal NP carrier

Factors Enhancing Uptake of NP in the Gut Associated Lymphoid Tissue (GALT) Florence (1997, 2005) suggested several factors Stability of NP in the gut lumen Submicron particle size < 5 μm Lack of surface charge Shape effects not clear – elasticity important for transport in blood vessels Surface hydrophobocity Presence of specific ligands – lectins and invasins – for uptake by epithelial cells, but not transport

Dietary supplements used in the oral exposure pathway Nutritional research in uptake of nanoscale nutrients provides additional lines of evidence for risk assessment Data on oral toxicity testing of NP of nutritional interest exists (red elemental selenium and curcumin) Uptake of colloidal forms of nutrients may provide data

Food Processing Naturally-occurring nanoscale structures in food influence processing techniques Nanoscale foams, emulsions, micelles and surfactants have been used throughout historical time Examining how these natural nanoscale structures facilitate or inhibit uptake, transport or distribution could inform risk assessments for ENM

Molecular Gastronomy Science of Culinary Processes Increased interest in the chemistry and physics behind recipes – why mayonnaise becomes firm or soufflés rise Molecular gastronomy scientists studying the evolution of sauces have identified 23 different complex disperse systems in French cuisine Categorizing consistency of foods and relating that to how water is organized in those foods at the molecular level

Problem Formulation Uncertainty can be reduced by framing the problem to be assessed The range of expected use (and misuse) provides a boundary about the system of interest and will eliminate encyclopedic analysis of all uncertainty Limits analysis to only uncertainty that is relevant to the issue addressed by the assessment

Characterizing Uncertainty Quantitative techniques to address uncertainty - parameter uncertainty or model uncertainty (sensitivity analysis, uncertainty analysis) Qualitative techniques also available for non- quantitative models - expert elicitation Uncertainty should be discussed in the risk assessment

Communicating Uncertainty to Decision Makers and the Public Uncertainty - and its impact on the risk estimate - should be disclosed to the decision maker and the public